H Clifford Lane
Biographic Data
| ID | 9022919 |
|---|---|
| NAME | H Clifford Lane |
| GIVEN NAMES | H Clifford |
| FAMILY NAME | Lane |
| SIGNATURE | LANE H C |
| AFFILIATIONS | National Institute of Allergy and Infectious Diseases |
| ORCID | 0000-0001-9509-1045 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
International clinical research networks – a collaborative approach for pandemic preparedness and response
In the last 100 years, the world has experienced four influenza pandemics, with an occurrence every 15-30 years resulting in an annual probability of 3% to 7% [1]. More recently, other pathogens including SARS, MERS, and the recent SARS CoV-2, have stressed the need to improve pandemic preparedness and response capabilities. Developing strategies to promote [...]
David
DAVID is a popular bioinformatics resource system including a web server and web service for functional annotation and enrichment analyses of gene lists. It consists of a comprehensive knowledgebase and a set of functional analysis tools. Here, we report all updates made in 2021. The DAVID Gene system was rebuilt to gain coverage of more organisms, which increased the taxonomy coverage from 17 399 to 55 464. All existing annotation types have bee…
Covid-19
Remdesivir for the Treatment of Covid-19 — Final Report
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (2…
Covid-19 — Navigating the Uncharted
Covid-19 — Navigating the Uncharted Fauci, Lane, and Redfield comment on the early clinical features and epidemiology of cases reported in Wuhan, China, along with current mortality data, noting th...
No prominent works on this page.
Covid-19
Remdesivir for the Treatment of Covid-19 — Final Report
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (2…
Covid-19 — Navigating the Uncharted
Covid-19 — Navigating the Uncharted Fauci, Lane, and Redfield comment on the early clinical features and epidemiology of cases reported in Wuhan, China, along with current mortality data, noting th...
David
DAVID is a popular bioinformatics resource system including a web server and web service for functional annotation and enrichment analyses of gene lists. It consists of a comprehensive knowledgebase and a set of functional analysis tools. Here, we report all updates made in 2021. The DAVID Gene system was rebuilt to gain coverage of more organisms, which increased the taxonomy coverage from 17 399 to 55 464. All existing annotation types have bee…
International clinical research networks – a collaborative approach for pandemic preparedness and response
In the last 100 years, the world has experienced four influenza pandemics, with an occurrence every 15-30 years resulting in an annual probability of 3% to 7% [1]. More recently, other pathogens including SARS, MERS, and the recent SARS CoV-2, have stressed the need to improve pandemic preparedness and response capabilities. Developing strategies to promote [...]
2019-20 coronavirus outbreak (4 works) · Medicine (4 works) · Outbreak (4 works) · Coronavirus disease 2019 (COVID-19) (3 works) · COVID-19 Clinical Research Studies (3 works) · Disease (3 works) · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (3 works) · Virology (3 works) · COVID-19 and healthcare impacts (2 works) · COVID-19 epidemiological studies (2 works)